Caribou Biosciences, Inc.

Unity Biotechnology, a biotech firm developing drugs that eliminate or modulate senescent cells to treat diseases of aging, has been making the case for its approach in retinal diseases for the last f

Oncology is, by far, the most lucrative market within biopharma, with Evaluate 2030 sales predictions of more than twice that of the next therapeutic area. In this contested and increasingly granular

Oncology is, by far, the most lucrative market within biopharma, with Evaluate 2030 sales predictions of more than twice that of the next therapeutic area. In this contested and increasingly granular

As the pharmaceutical sector continues to evolve, the landscape of sales-driving indications is set to undergo transformation by 2030. In this article In Vivo delves into the therapeutic areas poise